Treatment Blood Pressure

Scientists are developing new medications to treat resistant hypertension. One such drug, called Baxdrostat, has shown promising results in phase 2 trials. This drug can substantially reduce blood pressure in people with treatment-resistant hypertension. 

Quantity

New Developments in Hypertension Treatment

Baxdrostat: A New Hope

Scientists are developing new medications to treat resistant hypertension. One such drug, called Baxdrostat, has shown promising results in phase 2 trials. This drug can substantially reduce blood pressure in people with treatment-resistant hypertension. The results support the idea that some cases of treatment-resistant hypertension may be caused by the hormone aldosterone.

Understanding Blood Pressure

Blood pressure is a measure of the blood pushing against the walls of the arteries. It consists of two numbers — one which represents the systolic pressure when the heart beats and the other of the diastolic pressure between heartbeats. Healthy blood pressure is up to 120 mmHg systolic and 80 mmHg diastolic. Anything consistently above 130 mmHg and 80 mmHg is considered high or hypertensive according to the U.S. 2017 clinical practice guidelines.

The Risks of Hypertension

Persistent high blood pressure is linked to an increased risk of life-threatening health conditions such as stroke and heart disease, two of the leading causes of death in the United States. Hypertension has no symptoms or warning signs, and the only way to know blood pressure levels is to have them tested regularly.

Treatment-Resistant Hypertension

An estimated 12% of people with hypertension have treatment-resistant hypertension (tRH), equating to around 7.6 million people¹. Resistant hypertension is classified as having high blood pressure that persists despite using at least three different types of blood pressure-lowering medications. This can substantially increase the patient’s risk of cardiovascular disease and renal failure.

The Future of Hypertension Treatment

The study on Baxdrostat, published in The New England Journal of Medicine and presented at the American Heart Association Scientific conference, offers hope to people living with uncontrolled high blood pressure¹. As research continues, we can look forward to more advancements in the treatment of hypertension.

Remember, it's important to consult with a healthcare professional for personalized medical advice. This article is intended for informational purposes only.